AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Rosuvastatin Calcium in South Africa
5 products registered with SAHPRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LYPSTAPLUS 10 mg/10 mg | 55/7.5/0779 | Abbott Laboratories S.A. (Pty) Ltd | active | 23 Jan 2029 |
| LYPSTAPLUS 20 mg/10 mg | 55/7.5/0780 | Abbott Laboratories S.A. (Pty) Ltd | active | 23 Jan 2029 |
| ROCREST 20 | 46/7.5/0327 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| ROCREST 40 | 46/7.5/0328 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| ROCREST 10 | 46/7.5/0326 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
Rosuvastatin Calcium — SAHPRA Registration Details
SAHPRA (South Africa) has 5 registered products containing Rosuvastatin Calcium, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Rosuvastatin Calcium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.